Analgesics in Canada

  • ID: 4420029
  • Report
  • Region: Canada
  • 19 Pages
  • Euromonitor International
1 of 4
Analgesics is a mature OTC product type in Canada. The ageing population trend remains the key factor behind the stable demand for analgesics. The population is expected to experience a falling birth rate caused by a drop in the proportion of women of childbearing age. Meanwhile, the 65-year-old-and-over population is set to grow over the forecast period.

The Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
ANALGESICS IN CANADA

List of Contents and Tables
  • Headlines
  • Prospects
  • Analgesics Is Driven by the Demand From An Ageing Population
  • Potential Side Effects Cause Concerns
  • Topical Analgesics/anaesthetic Posts the Fastest Retail Value Sales Growth
  • Competitive Landscape
  • Analgesics Is Dominated by Large Pharmaceutical Companies
  • Private Label Retailers Try To Compete With Large Pharmaceutical Companies
  • Companies Launch Solutions To Address Multiple Symptoms and Improve Efficacy
  • Category Data
  • Table 1 Sales of Analgesics by Category: Value 2012-2017
  • Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  • Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  • Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  • Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
  • Executive Summary
  • Consumer Health Continues To Develop and Grow in Canada
  • Consumer Health Experiences Steady Value Growth in 2017
  • Intense Competition in A Fragmented Competitive Landscape
  • Drugstores/parapharmacies Dominates Distribution in 2017
  • Growth Opportunities To Be Explored in the Forecast Period
  • Market Indicators
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 9 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 10 Sales of Consumer Health by Category: Value 2012-2017
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Sources
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll